Good conservative summary about ipilimumab, braf inhibitors and ckit inhibitors.

New and emerging approaches to the treatment of melanoma are described by Daniel G. Coit, MD, from Memorial Sloan-Kettering Cancer Center in this video from the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers dedicated to improving the quality and effectiveness of care for cancer patients. For more information on melanoma and other cancers, including the NCCN Guidelines for Patients, visit